Krilogy Financial LLC Makes New Investment in Intuitive Surgical, Inc. $ISRG

Krilogy Financial LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,109 shares of the medical equipment provider’s stock, valued at approximately $3,179,000.

Other hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC boosted its holdings in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the last quarter. Sivia Capital Partners LLC lifted its position in Intuitive Surgical by 3.8% during the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after buying an additional 34 shares during the period. Sequoia Financial Advisors LLC boosted its stake in Intuitive Surgical by 12.8% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 9,684 shares of the medical equipment provider’s stock worth $5,263,000 after buying an additional 1,097 shares during the last quarter. Cornerstone Wealth Group LLC boosted its stake in Intuitive Surgical by 20.1% in the 2nd quarter. Cornerstone Wealth Group LLC now owns 764 shares of the medical equipment provider’s stock worth $415,000 after buying an additional 128 shares during the last quarter. Finally, Moran Wealth Management LLC grew its holdings in Intuitive Surgical by 44.0% in the 2nd quarter. Moran Wealth Management LLC now owns 2,476 shares of the medical equipment provider’s stock valued at $1,345,000 after buying an additional 757 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $496.12 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08. The stock’s 50-day simple moving average is $545.21 and its 200-day simple moving average is $510.52. The firm has a market cap of $176.19 billion, a price-to-earnings ratio of 62.88, a PEG ratio of 3.84 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the prior year, the business posted $2.21 earnings per share. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on ISRG shares. BTIG Research reiterated a “buy” rating and set a $616.00 price objective on shares of Intuitive Surgical in a report on Friday, January 23rd. Raymond James Financial upped their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Daiwa Securities Group upped their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. Finally, Leerink Partners increased their target price on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $617.23.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. This trade represents a 50.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the sale, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. The trade was a 16.77% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 56,189 shares of company stock worth $30,785,441 over the last three months. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Quarterly beat and procedure momentum support fundamentals — Intuitive’s Jan. quarter topped EPS and revenue estimates and management highlighted continued adoption of the da Vinci 5 platform, reinforcing the company’s growth narrative. MarketBeat: Growth Engine
• Positive Sentiment: Analyst coverage remains mixed but contains notable buy-side views — several firms keep buy/overweight ratings and high targets (e.g., Barclays, BTIG, Leerink), supporting investor conviction that upside remains if execution continues. Globe and Mail: Analyst Insights
• Neutral Sentiment: Technical and market-data focus — traders are watching the pullback and key moving averages (50‑day vs. 200‑day) using interactive charting tools, which can amplify short‑term moves but are not fundamental drivers. Barron’s Interactive Chart
• Neutral Sentiment: Short-interest figures in recent feeds appear anomalous (zeros/NaN) and likely aren’t a meaningful market driver today; treat those data points with caution.
• Negative Sentiment: Insider selling flagged — EVP Myriam Curet and VP Fredrik Widman disclosed multiple share sales in early February, with Curet reducing her holding materially; such filings often create short‑term negative sentiment. Curet SEC filing Widman SEC filing
• Negative Sentiment: Valuation questions and recent underperformance — financial press pieces are asking whether ISRG is still “priced for perfection” after a pullback, and analysts note the shares have materially underperformed the market in recent months, which may sustain near‑term caution. Yahoo Finance: Valuation Debate Zacks: Share Pullback

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.